Bluebird Bio will sell itself to private equity firms Carlyle and SK Capital for about $30 million, the company said Friday.

There is a catch. If the private equity firms can boost sales of bluebird’s three gene therapies to $600 million—over any ...

Wall Street is still awaiting regulatory approval for the first full-blown private-asset ETFs, but for now opportunistic ...

Allspring Global Investments Holdings LLC raised its holdings in shares of Brookfield Co. (NYSE:BN – Free Report) by 1.3% in the 4th quarter, according to its most recent 13F filing with the ...

One of the nation’s largest private hospital operators, Healthscope, has shut down another location, continuing the trend of ...

Ramsay Healthcare and St John of God Health Care have emerged as potential players in the race to save Healthscope.

We came across a bullish thesis on Brookfield Asset Management Ltd. (BAM) on Substack by Soren Peterson. In this article, we ...

Brookfield, Wisconsin-based MLG Capital, a provider of diversified private real estate ­investments, launched its MLG Private Fund VII, the seventh fund in the firm’s series of diversified private ...

The 8 analysts following Brookfield have set target prices ranging from $41.0 to $80.0 per share, for an average of $67.5 ...

Mike Bock, co-founder of Petrie Partners, shares his perspective on how deals will be made in oil and gas this year in an ...

Brookfield Renewable Partners (BEP) offers a 6.66% yield, strong growth potential, and global diversification. Discover why ...

We recently compiled a list of the 10 Best Performing Canadian Stocks in 2025. In this article, we are going to take a look ...